Colony-stimulating factor-1-induced AIF1 expression in tumor-associated macrophages enhances the progression of hepatocellular carcinoma

scientific article published on 26 May 2017

Colony-stimulating factor-1-induced AIF1 expression in tumor-associated macrophages enhances the progression of hepatocellular carcinoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1080/2162402X.2017.1333213
P932PMC publication ID5599077
P698PubMed publication ID28932635

P50authorHao CaiQ61090174
Xiao-Dong ZhuQ83249510
Hui-Chuan SunQ90958061
P2093author name stringYuan-Yuan Zhang
Xiao-Long Li
Zong-Tao Chai
Bo-Gen Ye
Jian-Yang Ao
Cheng-Hao Wang
Man-Qing Cao
Wen-Kai Shi
P2860cites workDaintain/AIF-1 Plays Roles in Coronary Heart Disease via Affecting the Blood Composition and Promoting Macrophage Uptake and Foam Cell FormationQ43841202
P48 is a predictive marker for outcome of postoperative interferon-alpha treatment in patients with hepatitis B virus infection-related hepatocellular carcinoma.Q45412652
Robo1 promotes angiogenesis in hepatocellular carcinoma through the Rho family of guanosine triphosphatases' signaling pathwayQ52940263
Allograft inflammatory factor-1 defines a distinct subset of infiltrating macrophages/microglial cells in rat and human gliomas.Q55474955
CCL2 Shapes Macrophage Polarization by GM-CSF and M-CSF: Identification of CCL2/CCR2-Dependent Gene Expression ProfileQ61865899
Micrometastases of solitary hepatocellular carcinoma and appropriate resection marginQ79777704
Prognostic impact of anatomic resection for hepatocellular carcinomaQ80926831
High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinomaQ81351659
Resection of hepatocellular carcinoma without cirrhosisQ83276731
Long-term survival analysis of pure laparoscopic versus open hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a single-center experienceQ85856027
Polarized CD163+ tumor-associated macrophages are associated with increased angiogenesis and CXCL12 expression in gastric cancerQ86570584
CCL18 from Tumor-Associated Macrophages Promotes Breast Cancer Metastasis via PITPNM3Q24299518
Cloning and characterization of allograft inflammatory factor-1: a novel macrophage factor identified in rat cardiac allografts with chronic rejectionQ24320807
Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell TumorQ27701677
Management of hepatocellular carcinoma: An updateQ27860530
Immunity, Inflammation, and CancerQ27861048
Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expressionQ28646286
Macrophage activation and polarization: nomenclature and experimental guidelinesQ29620642
Macrophages.com: an on-line community resource for innate immunity researchQ34021207
The colony-stimulating factor-1 (CSF-1) receptor sustains ERK1/2 activation and proliferation in breast cancer cell linesQ34077902
EGFR has a tumour-promoting role in liver macrophages during hepatocellular carcinoma formationQ34282375
Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial.Q34573686
Intracellular signaling in M-CSF-induced microglia activation: role of Iba1.Q34963694
CSF-1R inhibition alters macrophage polarization and blocks glioma progressionQ34993852
Rac2 controls tumor growth, metastasis and M1-M2 macrophage differentiation in vivoQ35158209
High expression of macrophage colony-stimulating factor-1 receptor in peritumoral liver tissue is associated with poor outcome in hepatocellular carcinoma after curative resectionQ35584172
The Global Burden of Cancer 2013Q35847426
Resection of hepatocellular cancer ≤2 cm: results from two Western centers.Q36233505
Closed chromatin architecture is induced by an RNA duplex targeting the HIV-1 promoter regionQ36838738
SRF promotes gastric cancer metastasis through stromal fibroblasts in an SDF1-CXCR4-dependent mannerQ37564655
The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets.Q37800217
Tumor-associated macrophages as major players in the tumor microenvironmentQ38240110
Cancer-associated fibroblasts promote hepatocellular carcinoma metastasis through chemokine-activated hedgehog and TGF-β pathwaysQ38769001
Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinomaQ38829170
Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma.Q38934719
Depletion of tumor-associated macrophages enhances the effect of sorafenib in metastatic liver cancer models by antimetastatic and antiangiogenic effects.Q39689403
Daintain/AIF-1 promotes breast cancer proliferation via activation of the NF-kappaB/cyclin D1 pathway and facilitates tumor growthQ40002372
Allograft inflammatory factor-1 augments macrophage phagocytotic activity and accelerates the progression of atherosclerosis in ApoE-/- miceQ40023211
M-CSF and GM-CSF Receptor Signaling Differentially Regulate Monocyte Maturation and Macrophage Polarization in the Tumor Microenvironment.Q40316330
CXCL16 signaling mediated macrophage effects on tumor invasion of papillary thyroid carcinomaQ40331716
Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loopQ40408955
Allograft inflammatory factor‐1 augments production of interleukin‐6, ‐10and ‐12 by a mouse macrophage lineQ40766609
The Inflammatory Microenvironment in Hepatocellular Carcinoma: A Pivotal Role for Tumor-Associated MacrophagesQ41481421
CSF-1 signal transductionQ41566990
Inhibition of AIF-1 expression by constitutive siRNA expression reduces macrophage migration, proliferation, and signal transduction initiated by atherogenic stimuliQ42486573
P433issue9
P304page(s)e1333213
P577publication date2017-05-26
P1433published inOncoImmunologyQ18026500
P1476titleColony-stimulating factor-1-induced AIF1 expression in tumor-associated macrophages enhances the progression of hepatocellular carcinoma
P478volume6

Reverse relations

cites work (P2860)
Q89941808AIF1 was identified as an up-regulated gene contributing to CSFV Shimen infection in porcine alveolar macrophage 3D4/21 cells
Q58762819Absence of AIF1L contributes to cell migration and a poor prognosis of breast cancer
Q91670603Activation of the IL-4/STAT6 Signaling Pathway Promotes Lung Cancer Progression by Increasing M2 Myeloid Cells
Q58579151An isoform of AIF1 involved in breast cancer
Q90133943CXCL16 positively correlated with M2-macrophage infiltration, enhanced angiogenesis, and poor prognosis in thyroid cancer
Q90220130Current Status and Future Direction of Immunotherapy in Hepatocellular Carcinoma: What Do the Data Suggest?
Q90403237Expression of Programmed Cell Death-Ligands in Hepatocellular Carcinoma: Correlation With Immune Microenvironment and Survival Outcomes
Q89998270From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma
Q90270048Inflammatory Mechanisms of HCC Development
Q91828621MIR22HG As A Tumor Suppressive lncRNA In HCC: A Comprehensive Analysis Integrating RT-qPCR, mRNA-Seq, And Microarrays
Q59129855Novel protein signatures suggest progression to muscular invasiveness in bladder cancer

Search more.